公开(公告)号：US20150344422A1

公开(公告)日：2015-12-03

申请号：US14655476

申请日：2014-03-12

申请人： LUPIN LIMITED

发明人： Neelima Sinha ,  Navnath Popat Karche ,  Shridhar Keshav Adurkar ,  Venkata P. Palle ,  Rajender Kumar Kamboj

IPC分类号： C07D207/323 ,  A61K45/06 ,  A61K31/401

CPC分类号： C07D207/323 ,  A61K31/401 ,  A61K45/06 ,  C07D207/34 ,  C07D401/04 ,  C07D403/06

摘要： Disclosed are compounds of the Formula (I), wherein R1, R2, R3, R4, R5, R6, R7 and m are as described herein, as modulators of the nicotinic acetylcholine receptors, particularly the α7 subtype, their tautomeric forms, stereoisomers, and their pharmaceutically acceptable salts, pharmaceutical compositions thereof, and combinations thereof with suitable other medicaments. Also disclosed are a process of preparation of the compounds and the intended uses thereof in therapy, particularly in the prophylaxis and/or treatment of disorders such as Alzheimer's disease, mild cognitive impairment, and senile dementia.

摘要翻译： 公开了式（I）的化合物，其中R 1，R 2，R 3，R 4，R 5，R 6，R 7和m如本文所述，作为烟碱乙酰胆碱受体的调节剂，特别是α7亚型，其互变异构体形式，立体异构体， 及其药学上可接受的盐，药物组合物及其与合适的其它药物的组合。 还公开了化合物的制备方法及其在治疗中的预期用途，特别是在诸如阿尔茨海默氏病，轻度认知障碍和老年痴呆症的疾病的预防和/或治疗中。

公开(公告)号：US20160137600A1

公开(公告)日：2016-05-19

申请号：US14898773

申请日：2014-06-16

申请人： LUPIN LIMITED

发明人： Neelima Sinha ,  Navnath Popat Karche ,  Shridhar Keshav Adurkar ,  Dnyaneshwar Changdeo Bhanage ,  Venkata P. Palle ,  Rajender Kumar Kamboj

IPC分类号： C07D207/333 ,  A61K31/4439 ,  C07D401/06 ,  A61K31/40 ,  A61K45/06

CPC分类号： A61K31/4439 ,  A61K31/40 ,  A61K45/06 ,  C07D207/333 ,  C07D401/04 ,  C07D401/06

摘要： Disclosed are compounds of the formula (I), wherein R1, R2, R3, R4, R5, R6, R7 and m are as described herein, as modulators of the nicotinic acetylcholine receptors, particularly the α7 subtype, their tautomeric forms, stereoisomers, and their pharmaceutically acceptable salts, pharmaceutical compositions thereof, and combinations thereof with suitable other medicaments. Also disclosed are a process of preparation of the compounds and the intended uses thereof in therapy, particularly in the prophylaxis and/or treatment of disorders such as Alzheimer's disease, mild cognitive impairment, and senile dementia.

摘要翻译： 公开了式（I）的化合物，其中R1，R2，R3，R4，R5，R6，R7和m如本文所述，作为烟碱乙酰胆碱受体的调节剂，特别是α7亚型，其互变异构体形式，立体异构体， 及其药学上可接受的盐，药物组合物及其与合适的其它药物的组合。 还公开了化合物的制备方法及其在治疗中的预期用途，特别是在诸如阿尔茨海默氏病，轻度认知障碍和老年痴呆症的疾病的预防和/或治疗中。

公开(公告)号：US09617210B2

公开(公告)日：2017-04-11

申请号：US14655476

申请日：2014-03-12

申请人： Lupin Limited

发明人： Neelima Sinha ,  Navnath Popat Karche ,  Shridhar Keshav Adurkar ,  Venkata P. Palle ,  Rajender Kumar Kamboj

IPC分类号： C07D207/323 ,  A61K45/06 ,  A61K31/401 ,  C07D401/04 ,  C07D403/06 ,  C07D207/34

CPC分类号： C07D207/323 ,  A61K31/401 ,  A61K45/06 ,  C07D207/34 ,  C07D401/04 ,  C07D403/06

摘要： Disclosed are compounds of the Formula (I), wherein R1, R2, R3, R4, R5, R6, R7 and m are as described herein, as modulators of the nicotinic acetylcholine receptors, particularly the α7 subtype, their tautomeric forms, stereoisomers, and their pharmaceutically acceptable salts, pharmaceutical compositions thereof, and combinations thereof with suitable other medicaments. Also disclosed are a process of preparation of the compounds and the intended uses thereof in therapy, particularly in the prophylaxis and/or treatment of disorders such as Alzheimer's disease, mild cognitive impairment, and senile dementia.

公开(公告)号：US09504680B2

公开(公告)日：2016-11-29

申请号：US14898773

申请日：2014-06-16

申请人： Lupin Limited

发明人： Neelima Sinha ,  Navnath Popat Karche ,  Shridhar Keshav Adurkar ,  Dnyaneshwar Changdeo Bhanage ,  Venkata P. Palle ,  Rajender Kumar Kamboj

IPC分类号： A61K31/4439 ,  C07D207/333 ,  C07D401/04 ,  A61K31/40 ,  A61K45/06 ,  C07D401/06

CPC分类号： A61K31/4439 ,  A61K31/40 ,  A61K45/06 ,  C07D207/333 ,  C07D401/04 ,  C07D401/06

摘要： Disclosed are compounds of the formula (I), wherein R1, R2, R3, R4, R5, R6, R7 and m are as described herein, as modulators of the nicotinic acetylcholine receptors, particularly the α7 subtype, their tautomeric forms, stereoisomers, and their pharmaceutically acceptable salts, pharmaceutical compositions thereof, and combinations thereof with suitable other medicaments. Also disclosed are a process of preparation of the compounds and the intended uses thereof in therapy, particularly in the prophylaxis and/or treatment of disorders such as Alzheimer's disease, mild cognitive impairment, and senile dementia.

公开(公告)号：US09388196B2

公开(公告)日：2016-07-12

申请号：US14379134

申请日：2013-02-22

申请人： Lupin Limited

发明人： Neelima Sinha ,  Navnath Popat Karche ,  Anil Kashiram Hajare ,  Shridhar Keshav Adurkar ,  Bikramjit Singh Lairikyengbam ,  Firoj Aftab Raje ,  Ajay Ramchandra Tilekar ,  Baban Rupaji Thube ,  Venkata P. Palle ,  Rajender Kumar Kamboj

IPC分类号： A61K31/5377 ,  A61K31/5386 ,  A61K31/454 ,  A61K31/439 ,  A61K31/427 ,  C07D417/14 ,  C07D417/06 ,  C07D417/04 ,  C07D498/08 ,  C07D277/56 ,  C07D221/22 ,  A61K45/06

CPC分类号： C07D498/08 ,  A61K31/427 ,  A61K31/439 ,  A61K31/454 ,  A61K31/5377 ,  A61K31/5386 ,  A61K45/06 ,  C07D221/22 ,  C07D277/56 ,  C07D417/04 ,  C07D417/06 ,  C07D417/14

摘要： Disclosed is a compound of formula (I) wherein Y, Ring D, m and R1-R4 are as described herein, as a modulator of nicotinic acetylcholine receptors particularly the α7 subtype, in a subject in need thereof, as well as pharmaceutically acceptable salts, polymorphs, solvates, and isomers thereofs, for use either alone or in combinations with suitable other medicaments, and pharmaceutical compositions containing such compounds. Also disclosed are a process of preparation of the compounds and the intended uses thereof in therapy, particularly in the prophylaxis and therapy of disorders such as Alzheimer's disease, mild cognitive impairment, senile dementia, and the like.

摘要翻译： 公开了其中Y，环D，m和R 1 -R 4如本文所述的式（I）化合物，作为需要其的受试者中烟碱乙酰胆碱受体，特别是α7亚型的调节剂，以及药学上可接受的盐 ，多晶型物，溶剂合物和异构体，单独使用或与合适的其它药物组合使用，以及含有这些化合物的药物组合物。 还公开了化合物的制备方法及其在治疗中的用途，特别是在诸如阿尔茨海默氏病，轻度认知障碍，老年痴呆等疾病的预防和治疗中。

公开(公告)号：US20150291617A1

公开(公告)日：2015-10-15

申请号：US14379134

申请日：2013-02-22

申请人： LUPIN LIMITED

发明人： Neelima Sinha ,  Navnath Popat Karche ,  Anil Kashiram Hajare ,  Shridhar Keshav Adurkar ,  Bikramjit Singh Lairikyengbam ,  Firoj Aftab Raje ,  Ajay Ramchandra Tilekar ,  Baban Rupaji Thube ,  Venkata P. Palle ,  Rajender Kumar Kamboj

IPC分类号： C07D498/08 ,  C07D221/22 ,  A61K31/439 ,  C07D417/06 ,  A61K45/06 ,  C07D277/56 ,  A61K31/454 ,  C07D417/04 ,  A61K31/427 ,  A61K31/5386 ,  A61K31/5377

CPC分类号： C07D498/08 ,  A61K31/427 ,  A61K31/439 ,  A61K31/454 ,  A61K31/5377 ,  A61K31/5386 ,  A61K45/06 ,  C07D221/22 ,  C07D277/56 ,  C07D417/04 ,  C07D417/06 ,  C07D417/14

摘要： Disclosed is a compound of formula (I) wherein Y, Ring D, m and R1-R4 are as described herein, as a modulator of nicotinic acetylcholine receptors particularly the α7 subtype, in a subject in need thereof, as well as pharmaceutically acceptable salts, polymorphs, solvates, and isomers thereofs, for use either alone or in combinations with suitable other medicaments, and pharmaceutical compositions containing such compounds. Also disclosed are a process of preparation of the compounds and the intended uses thereof in therapy, particularly in the prophylaxis and therapy of disorders such as Alzheimer's disease, mild cognitive impairment, senile dementia, and the like.

摘要翻译： 公开了其中Y，环D，m和R 1 -R 4如本文所述的式（I）化合物，作为需要其的受试者中烟碱乙酰胆碱受体，特别是α7亚型的调节剂，以及药学上可接受的盐 ，多晶型物，溶剂合物和异构体，单独使用或与合适的其它药物组合使用，以及含有这些化合物的药物组合物。 还公开了化合物的制备方法及其在治疗中的用途，特别是在诸如阿尔茨海默氏病，轻度认知障碍，老年痴呆等疾病的预防和治疗中。